1976
DOI: 10.1016/s0140-6736(76)92217-0
|View full text |Cite
|
Sign up to set email alerts
|

Long-Term Prevention of Postmenopausal Osteoporosis by Œstrogen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
181
0
4

Year Published

1981
1981
2006
2006

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 921 publications
(191 citation statements)
references
References 17 publications
5
181
0
4
Order By: Relevance
“…The reduction in the femur weight may be associated with the well known decrease in bone formation in the absence of estrogens. 26,27 The reduction in the weight of several organs with OVX indicates that normal estrogen levels are necessary for the normal growth of these organs. Rats used in the present experiment were relatively young animals (6 weeks) whose maturation was not complete.…”
Section: Body Composition In Ovariectomized Trained Ratsmentioning
confidence: 99%
“…The reduction in the femur weight may be associated with the well known decrease in bone formation in the absence of estrogens. 26,27 The reduction in the weight of several organs with OVX indicates that normal estrogen levels are necessary for the normal growth of these organs. Rats used in the present experiment were relatively young animals (6 weeks) whose maturation was not complete.…”
Section: Body Composition In Ovariectomized Trained Ratsmentioning
confidence: 99%
“…Postmenopausal osteoporosis is delayed or prevented by substitution with estrogens (1)(2)(3). The mechanism by which estrogens exert their effects on bone is unknown, although it is thought that, at least in part, they may inhibit bone resorption (3).…”
mentioning
confidence: 99%
“…"-' 5 It also appears that time of initiation, and length and continuity of estrogen drug therapy influence rate and amount of bone loss. [16][17][18][19] Until recently, however, the effect of estrogen drug treatment in preventing the clinical outcomes of osteoporosis, such as hip fractures, had not been investigated. A recent study of medical records showed no significant protective effect of conjugated estrogen exposure of six months or longer upon the hip and distal radius fracture experience of 157 matched case-control pairs of postmenopausal females.…”
mentioning
confidence: 99%